Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $139.6100 (1.62%) ($139.6100 - $139.6100) on Wed. Mar. 31, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.17% (three month average) | RSI | 28 | Latest Price | $139.6100(1.62%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN declines -3.8% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IBB(50%) XBI(43%) ARKG(36%) IWO(34%) ARKK(31%) | Factors Impacting SGEN price | SGEN will decline at least -1.585% in a week (0% probabilities). VIXM(-22%) VXX(-10%) UUP(-9%) IGOV(-4%) TBT(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.585% (StdDev 3.17%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $134.42(-3.72%) | Inflection Point | Yes | Resistance Level | $145.45 | 5 Day Moving Average | $139.03(0.42%) | 10 Day Moving Average | $141.69(-1.47%) | 20 Day Moving Average | $145.45(-4.02%) | To recent high | -27.1% | To recent low | 1.6% | Market Cap | $24.273b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |